The Directorate General of Drug Administration (DGDA) of Bangladesh has approved the second Chinese COVID 19 vaccine ‘CoronaVac’ manufactured by the Sinovac company. The World Health Organisation (WHO) has already approved the Sinovac corona vaccine on June 1.
In a press release the DGDA said that this is the fifth vaccine for which emergency use authorisation has been provided for Bangladesh. Earlier, emergency use authorisation was granted to another Chinese vaccine Sinopharm, Russian Sputnik V, Oxford-AstraZeneca and Pfizer vaccines.
Meanwhile, the Chinese Deputy Ambassador to Bangladesh said that another batch of 6 lakh Chinese Sinoform vaccines will arrive in Bangladesh as a gift. China had gifted five lakh doses earlier on 12 May.
Bangladesh had entered into a commercial agreement with Serum Institute of India (SII) for the supply of 30 million doses of Oxford-AstraZeneca COVID vaccines to India out of which 7 million doses have been supplied. India also gifted close to 3 million doses of the vaccine to Bangladesh.